MAP1LC3A and hepatocellular carcinoma: The analysis of LC3 expression in tumor and ANT tissues, in conjunction with an assessment of HCC recurrence status, HCC etiology, the presence of cirrhosis and antiviral therapy status, can aid in identifying patients at risk of mortality after curative resection.